Cargando…

COVID-19-induced postural orthostatic tachycardia syndrome treated with ivabradine

A 22-year-old woman was referred with exertional dyspnoea and chest tightness 3 weeks following a diagnosis of COVID-19. Evaluation revealed a resting sinus tachycardia and criteria for postural orthostatic tachycardia syndrome were met. After non-pharmacological interventions failed to yield sympto...

Descripción completa

Detalles Bibliográficos
Autores principales: O'Sullivan, Jenna Stephanie, Lyne, Andrew, Vaughan, Carl J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204164/
https://www.ncbi.nlm.nih.gov/pubmed/34127505
http://dx.doi.org/10.1136/bcr-2021-243585
_version_ 1783708300487950336
author O'Sullivan, Jenna Stephanie
Lyne, Andrew
Vaughan, Carl J
author_facet O'Sullivan, Jenna Stephanie
Lyne, Andrew
Vaughan, Carl J
author_sort O'Sullivan, Jenna Stephanie
collection PubMed
description A 22-year-old woman was referred with exertional dyspnoea and chest tightness 3 weeks following a diagnosis of COVID-19. Evaluation revealed a resting sinus tachycardia and criteria for postural orthostatic tachycardia syndrome were met. After non-pharmacological interventions failed to yield symptomatic improvement, ivabradine was commenced. This intervention was followed by a substantial improvement in the patient’s exercise tolerance and energy levels and an objective reduction in supine and standing heart rate.
format Online
Article
Text
id pubmed-8204164
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-82041642021-06-28 COVID-19-induced postural orthostatic tachycardia syndrome treated with ivabradine O'Sullivan, Jenna Stephanie Lyne, Andrew Vaughan, Carl J BMJ Case Rep Case Report A 22-year-old woman was referred with exertional dyspnoea and chest tightness 3 weeks following a diagnosis of COVID-19. Evaluation revealed a resting sinus tachycardia and criteria for postural orthostatic tachycardia syndrome were met. After non-pharmacological interventions failed to yield symptomatic improvement, ivabradine was commenced. This intervention was followed by a substantial improvement in the patient’s exercise tolerance and energy levels and an objective reduction in supine and standing heart rate. BMJ Publishing Group 2021-06-14 /pmc/articles/PMC8204164/ /pubmed/34127505 http://dx.doi.org/10.1136/bcr-2021-243585 Text en © BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ. https://bmj.com/coronavirus/usageThis article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.
spellingShingle Case Report
O'Sullivan, Jenna Stephanie
Lyne, Andrew
Vaughan, Carl J
COVID-19-induced postural orthostatic tachycardia syndrome treated with ivabradine
title COVID-19-induced postural orthostatic tachycardia syndrome treated with ivabradine
title_full COVID-19-induced postural orthostatic tachycardia syndrome treated with ivabradine
title_fullStr COVID-19-induced postural orthostatic tachycardia syndrome treated with ivabradine
title_full_unstemmed COVID-19-induced postural orthostatic tachycardia syndrome treated with ivabradine
title_short COVID-19-induced postural orthostatic tachycardia syndrome treated with ivabradine
title_sort covid-19-induced postural orthostatic tachycardia syndrome treated with ivabradine
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204164/
https://www.ncbi.nlm.nih.gov/pubmed/34127505
http://dx.doi.org/10.1136/bcr-2021-243585
work_keys_str_mv AT osullivanjennastephanie covid19inducedposturalorthostatictachycardiasyndrometreatedwithivabradine
AT lyneandrew covid19inducedposturalorthostatictachycardiasyndrometreatedwithivabradine
AT vaughancarlj covid19inducedposturalorthostatictachycardiasyndrometreatedwithivabradine